292 related articles for article (PubMed ID: 27391422)
1. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC.
Gong L; Song J; Lin X; Wei F; Zhang C; Wang Z; Zhu J; Wu S; Chen Y; Liang J; Fu X; Lu J; Zhou C; Song L
J Pathol; 2016 Oct; 240(2):184-96. PubMed ID: 27391422
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.
Liu H; Hu X; Zhu Y; Jiang G; Chen S
Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824
[TBL] [Abstract][Full Text] [Related]
3. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling.
Fang L; Cai J; Chen B; Wu S; Li R; Xu X; Yang Y; Guan H; Zhu X; Zhang L; Yuan J; Wu J; Li M
Nat Commun; 2015 Oct; 6():8640. PubMed ID: 26468775
[TBL] [Abstract][Full Text] [Related]
5. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
[TBL] [Abstract][Full Text] [Related]
6. Chimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasion.
Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q
Mol Med Rep; 2017 Aug; 16(2):2121-2127. PubMed ID: 28656224
[TBL] [Abstract][Full Text] [Related]
7. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
9. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
10. Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer.
Huang JQ; Duan LX; Liu QY; Li HF; Hu AP; Song JW; Lin C; Huang B; Yao D; Peng B; Sun Y; Wen Y; Yang L; Xu X; Gong LY
Oncogene; 2023 Apr; 42(15):1233-1246. PubMed ID: 36869126
[TBL] [Abstract][Full Text] [Related]
11. The many faces of SRPK1.
Bullock N; Oltean S
J Pathol; 2017 Mar; 241(4):437-440. PubMed ID: 27859253
[TBL] [Abstract][Full Text] [Related]
12. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
14. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
Shu X; Chen M; Liu SY; Yu L; Sun LX; Sun LC; Ran YL
Cancer Med; 2023 Feb; 12(4):4510-4520. PubMed ID: 36047666
[TBL] [Abstract][Full Text] [Related]
15. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
16. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
17. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
18. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
19. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
20. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
